Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Revvity Inc. (RVTY : NYSE)
 
 • Company Description   
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $89.52 Daily Weekly Monthly
20 Day Moving Average: 1,367,755 shares
Shares Outstanding: 113.38 (millions)
Market Capitalization: $10,149.39 (millions)
Beta: 1.01
52 Week High: $128.29
52 Week Low: $81.36
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.33% -2.12%
12 Week 0.08% -3.67%
Year To Date -19.79% -29.80%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
77 4TH AVENUE
-
WALTHAM,MA 02451
USA		 ph: 781-663-6900
fax: 781-663-5985		 ir@revvity.com http://www.revvity.com
 
 • General Corporate Information   
Officers
Prahlad Singh - President and Chief Executive Officer
Maxwell Krakowiak - Senior Vice President and Chief Financial Officer
Anita Gonzales - Vice President and Controller
Peter Barrett - Director
Samuel R. Chapin - Director

Peer Information
Revvity Inc. (CHCR)
Revvity Inc. (ESRX)
Revvity Inc. (MYDP)
Revvity Inc. (COR)
Revvity Inc. (GBCS)
Revvity Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 714046109
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 01/30/26
Share - Related Items
Shares Outstanding: 113.38
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.01
Market Capitalization: $10,149.39 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.31%
Current Fiscal Quarter EPS Consensus Estimate: $1.54 Indicated Annual Dividend: $0.28
Current Fiscal Year EPS Consensus Estimate: $4.92 Payout Ratio: 0.06
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 6.16% Last Dividend Paid: 10/17/2025 - $0.07
Next EPS Report Date: 01/30/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.21
Trailing 12 Months: 18.69
PEG Ratio: 2.96
Price Ratios
Price/Book: 1.41
Price/Cash Flow: 10.51
Price / Sales: 3.61
EPS Growth
vs. Year Ago Period: -7.81%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 2.18%
vs. Previous Quarter: -2.96%
ROE
09/30/25 - 7.52
06/30/25 - 7.66
03/31/25 - 7.73
ROA
09/30/25 - 4.61
06/30/25 - 4.73
03/31/25 - 4.72
Current Ratio
09/30/25 - 1.75
06/30/25 - 3.33
03/31/25 - 3.58
Quick Ratio
09/30/25 - 1.44
06/30/25 - 2.75
03/31/25 - 2.99
Operating Margin
09/30/25 - 20.19
06/30/25 - 21.06
03/31/25 - 21.70
Net Margin
09/30/25 - 8.44
06/30/25 - 10.19
03/31/25 - 10.35
Pre-Tax Margin
09/30/25 - 9.64
06/30/25 - 11.29
03/31/25 - 12.06
Book Value
09/30/25 - 65.06
06/30/25 - 64.11
03/31/25 - 63.56
Inventory Turnover
09/30/25 - 3.32
06/30/25 - 3.20
03/31/25 - 3.12
Debt-to-Equity
09/30/25 - 0.36
06/30/25 - 0.43
03/31/25 - 0.41
Debt-to-Capital
09/30/25 - 26.29
06/30/25 - 29.84
03/31/25 - 29.32
 

Powered by Zacks Investment Research ©